Outcomes after diagnosis of mild cognitive impairment in a large autopsy series

Erin L. Abner, Richard J. Kryscio, Frederick A. Schmitt, David W. Fardo, Daniela C. Moga, Eseosa T. Ighodaro, Gregory A. Jicha, Lei Yu, Hiroko Dodge, Chengjie Xiong, Randall (Randy) Woltjer, Julie A. Schneider, Nigel J. Cairns, David A. Bennett, Peter T. Nelson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective: To determine clinical and neuropathological outcomes following a clinical diagnosis of mild cognitive impairment (MCI). Methods: Data were drawn from a large autopsy series (N = 1,337) of individuals followed longitudinally from normal or MCI status to death, derived from 4 Alzheimer Disease (AD) Centers in the United States. Results: Mean follow-up was 7.9 years. Of the 874 individuals ever diagnosed with MCI, final clinical diagnoses were varied: 39.2% died with an MCI diagnosis, 46.8% with a dementia diagnosis, and 13.9% with a diagnosis of intact cognition. The latter group had pathological features resembling those with a final clinical diagnosis of MCI. In terms of non-AD pathologies, both primary age-related tauopathy (p < 0.05) and brain arteriolosclerosis pathology (p < 0.001) were more severe in MCI than cognitively intact controls. Among the group that remained MCI until death, mixed AD neuropathologic changes (ADNC; ≥1 comorbid pathology) were more frequent than "pure" ADNC pathology (55% vs 22%); suspected non-Alzheimer pathology comprised the remaining 22% of cases. A majority (74%) of subjects who died with MCI were without "high"-level ADNC, Lewy body disease, or hippocampal sclerosis pathologies; this group was enriched in cerebrovascular pathologies. Subjects who died with dementia and were without severe neurodegenerative pathologies tended to have cerebrovascular pathology and carry the MCI diagnosis for a longer interval. Interpretation: MCI diagnosis usually was associated with comorbid neuropathologies; less than one-quarter of MCI cases showed "pure" AD at autopsy.

Original languageEnglish (US)
JournalAnnals of Neurology
DOIs
StateAccepted/In press - 2017

Fingerprint

Autopsy
Pathology
Dementia
Alzheimer Disease
Arteriolosclerosis
Cognitive Dysfunction
Tauopathies
Lewy Body Disease
Sclerosis
Cognition
Brain

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Abner, E. L., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Moga, D. C., Ighodaro, E. T., ... Nelson, P. T. (Accepted/In press). Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Annals of Neurology. https://doi.org/10.1002/ana.24903

Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. / Abner, Erin L.; Kryscio, Richard J.; Schmitt, Frederick A.; Fardo, David W.; Moga, Daniela C.; Ighodaro, Eseosa T.; Jicha, Gregory A.; Yu, Lei; Dodge, Hiroko; Xiong, Chengjie; Woltjer, Randall (Randy); Schneider, Julie A.; Cairns, Nigel J.; Bennett, David A.; Nelson, Peter T.

In: Annals of Neurology, 2017.

Research output: Contribution to journalArticle

Abner, EL, Kryscio, RJ, Schmitt, FA, Fardo, DW, Moga, DC, Ighodaro, ET, Jicha, GA, Yu, L, Dodge, H, Xiong, C, Woltjer, RR, Schneider, JA, Cairns, NJ, Bennett, DA & Nelson, PT 2017, 'Outcomes after diagnosis of mild cognitive impairment in a large autopsy series', Annals of Neurology. https://doi.org/10.1002/ana.24903
Abner, Erin L. ; Kryscio, Richard J. ; Schmitt, Frederick A. ; Fardo, David W. ; Moga, Daniela C. ; Ighodaro, Eseosa T. ; Jicha, Gregory A. ; Yu, Lei ; Dodge, Hiroko ; Xiong, Chengjie ; Woltjer, Randall (Randy) ; Schneider, Julie A. ; Cairns, Nigel J. ; Bennett, David A. ; Nelson, Peter T. / Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. In: Annals of Neurology. 2017.
@article{b0435a32422f401aa07f10d9fa7d94f8,
title = "Outcomes after diagnosis of mild cognitive impairment in a large autopsy series",
abstract = "Objective: To determine clinical and neuropathological outcomes following a clinical diagnosis of mild cognitive impairment (MCI). Methods: Data were drawn from a large autopsy series (N = 1,337) of individuals followed longitudinally from normal or MCI status to death, derived from 4 Alzheimer Disease (AD) Centers in the United States. Results: Mean follow-up was 7.9 years. Of the 874 individuals ever diagnosed with MCI, final clinical diagnoses were varied: 39.2{\%} died with an MCI diagnosis, 46.8{\%} with a dementia diagnosis, and 13.9{\%} with a diagnosis of intact cognition. The latter group had pathological features resembling those with a final clinical diagnosis of MCI. In terms of non-AD pathologies, both primary age-related tauopathy (p < 0.05) and brain arteriolosclerosis pathology (p < 0.001) were more severe in MCI than cognitively intact controls. Among the group that remained MCI until death, mixed AD neuropathologic changes (ADNC; ≥1 comorbid pathology) were more frequent than {"}pure{"} ADNC pathology (55{\%} vs 22{\%}); suspected non-Alzheimer pathology comprised the remaining 22{\%} of cases. A majority (74{\%}) of subjects who died with MCI were without {"}high{"}-level ADNC, Lewy body disease, or hippocampal sclerosis pathologies; this group was enriched in cerebrovascular pathologies. Subjects who died with dementia and were without severe neurodegenerative pathologies tended to have cerebrovascular pathology and carry the MCI diagnosis for a longer interval. Interpretation: MCI diagnosis usually was associated with comorbid neuropathologies; less than one-quarter of MCI cases showed {"}pure{"} AD at autopsy.",
author = "Abner, {Erin L.} and Kryscio, {Richard J.} and Schmitt, {Frederick A.} and Fardo, {David W.} and Moga, {Daniela C.} and Ighodaro, {Eseosa T.} and Jicha, {Gregory A.} and Lei Yu and Hiroko Dodge and Chengjie Xiong and Woltjer, {Randall (Randy)} and Schneider, {Julie A.} and Cairns, {Nigel J.} and Bennett, {David A.} and Nelson, {Peter T.}",
year = "2017",
doi = "10.1002/ana.24903",
language = "English (US)",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Outcomes after diagnosis of mild cognitive impairment in a large autopsy series

AU - Abner, Erin L.

AU - Kryscio, Richard J.

AU - Schmitt, Frederick A.

AU - Fardo, David W.

AU - Moga, Daniela C.

AU - Ighodaro, Eseosa T.

AU - Jicha, Gregory A.

AU - Yu, Lei

AU - Dodge, Hiroko

AU - Xiong, Chengjie

AU - Woltjer, Randall (Randy)

AU - Schneider, Julie A.

AU - Cairns, Nigel J.

AU - Bennett, David A.

AU - Nelson, Peter T.

PY - 2017

Y1 - 2017

N2 - Objective: To determine clinical and neuropathological outcomes following a clinical diagnosis of mild cognitive impairment (MCI). Methods: Data were drawn from a large autopsy series (N = 1,337) of individuals followed longitudinally from normal or MCI status to death, derived from 4 Alzheimer Disease (AD) Centers in the United States. Results: Mean follow-up was 7.9 years. Of the 874 individuals ever diagnosed with MCI, final clinical diagnoses were varied: 39.2% died with an MCI diagnosis, 46.8% with a dementia diagnosis, and 13.9% with a diagnosis of intact cognition. The latter group had pathological features resembling those with a final clinical diagnosis of MCI. In terms of non-AD pathologies, both primary age-related tauopathy (p < 0.05) and brain arteriolosclerosis pathology (p < 0.001) were more severe in MCI than cognitively intact controls. Among the group that remained MCI until death, mixed AD neuropathologic changes (ADNC; ≥1 comorbid pathology) were more frequent than "pure" ADNC pathology (55% vs 22%); suspected non-Alzheimer pathology comprised the remaining 22% of cases. A majority (74%) of subjects who died with MCI were without "high"-level ADNC, Lewy body disease, or hippocampal sclerosis pathologies; this group was enriched in cerebrovascular pathologies. Subjects who died with dementia and were without severe neurodegenerative pathologies tended to have cerebrovascular pathology and carry the MCI diagnosis for a longer interval. Interpretation: MCI diagnosis usually was associated with comorbid neuropathologies; less than one-quarter of MCI cases showed "pure" AD at autopsy.

AB - Objective: To determine clinical and neuropathological outcomes following a clinical diagnosis of mild cognitive impairment (MCI). Methods: Data were drawn from a large autopsy series (N = 1,337) of individuals followed longitudinally from normal or MCI status to death, derived from 4 Alzheimer Disease (AD) Centers in the United States. Results: Mean follow-up was 7.9 years. Of the 874 individuals ever diagnosed with MCI, final clinical diagnoses were varied: 39.2% died with an MCI diagnosis, 46.8% with a dementia diagnosis, and 13.9% with a diagnosis of intact cognition. The latter group had pathological features resembling those with a final clinical diagnosis of MCI. In terms of non-AD pathologies, both primary age-related tauopathy (p < 0.05) and brain arteriolosclerosis pathology (p < 0.001) were more severe in MCI than cognitively intact controls. Among the group that remained MCI until death, mixed AD neuropathologic changes (ADNC; ≥1 comorbid pathology) were more frequent than "pure" ADNC pathology (55% vs 22%); suspected non-Alzheimer pathology comprised the remaining 22% of cases. A majority (74%) of subjects who died with MCI were without "high"-level ADNC, Lewy body disease, or hippocampal sclerosis pathologies; this group was enriched in cerebrovascular pathologies. Subjects who died with dementia and were without severe neurodegenerative pathologies tended to have cerebrovascular pathology and carry the MCI diagnosis for a longer interval. Interpretation: MCI diagnosis usually was associated with comorbid neuropathologies; less than one-quarter of MCI cases showed "pure" AD at autopsy.

UR - http://www.scopus.com/inward/record.url?scp=85016009213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016009213&partnerID=8YFLogxK

U2 - 10.1002/ana.24903

DO - 10.1002/ana.24903

M3 - Article

C2 - 28224671

AN - SCOPUS:85016009213

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

ER -